Just a reminder that FXCRC sites are participating in Neuren's Fragile X trials. I'm guessing Neuren's trial may get a mention. If we are lucky.
"Neuren Pharmaceuticals (NEU) has received approval from the US Food and Drug Administration to conduct a Phase 2 clinical trial of a drug to treat patients with fragile X syndrome (FXS), the company recently announced. The trial is expected to start before the end of 2013, and is expected to involve several sites within the Fragile X Clinical & Research Consortium (FXCRC). - See more at: http://www.fragilex.org/2013/resear...-for-fragile-x-syndrome/#sthash.mQWV3nzc.dpuf"
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.45 |
Change
0.090(0.63%) |
Mkt cap ! $1.796B | |||
| Open | High | Low | Value | Volume |
| $14.49 | $14.61 | $14.32 | $1.529M | 105.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 179 | $14.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.46 | 426 | 4 |
View Market Depth
| Last trade - 13.21pm 15/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |